Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diverse Functional Autoantibodies in Patients with COVID-19
Eric Y. Wang, Tianyang Mao, Jon Klein, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 131

Showing 1-25 of 131 citing articles:

Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms
Amy D. Proal, Michael B. VanElzakker
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 729
The first 12 months of COVID-19: a timeline of immunological insights
Thiago de Amorim Carvalho, Florian Krammer, Akiko Iwasaki
Nature reviews. Immunology (2021) Vol. 21, Iss. 4, pp. 245-256
Open Access | Times Cited: 423
Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic
Kelvin Kai‐Wang To, Siddharth Sridhar, Kelvin Hei‐Yeung Chiu, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 507-535
Open Access | Times Cited: 297
Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms
Gerd Wallukat, Bettina Hohberger, Katrin Wenzel, et al.
Journal of Translational Autoimmunity (2021) Vol. 4, pp. 100100-100100
Open Access | Times Cited: 293
Post-COVID-19 Syndrome and the Potential Benefits of Exercise
Amaya Jimeno‐Almazán, Jesús G. Pallarés, Ángel Buendía‐Romero, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 10, pp. 5329-5329
Open Access | Times Cited: 291
Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1
Paul Bastard, Elizaveta Orlova, Leila Sozaeva, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 7
Open Access | Times Cited: 252
De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report
Shiv Gandhi, Jon Klein, Alexander J. Robertson, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 238
Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19
Can Liu, Andrew J. Martins, William Lau, et al.
Cell (2021) Vol. 184, Iss. 7, pp. 1836-1857.e22
Open Access | Times Cited: 207
Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome
Anthony L. Komaroff, W. Ian Lipkin
Trends in Molecular Medicine (2021) Vol. 27, Iss. 9, pp. 895-906
Open Access | Times Cited: 199
Passive transfer of fibromyalgia symptoms from patients to mice
Andreas Göebel, Emerson Krock, Clive Gentry, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 13
Open Access | Times Cited: 164
Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection
Dennis McGonagle, Gabriele De Marco, Charlie Bridgewood
Journal of Autoimmunity (2021) Vol. 121, pp. 102662-102662
Open Access | Times Cited: 155
Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died
Tom Aschman, Julia Schneider, Selina Greuel, et al.
JAMA Neurology (2021) Vol. 78, Iss. 8, pp. 948-948
Open Access | Times Cited: 140
Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome
Olga Sukocheva, Rebekah Maksoud, Narasimha M. Beeraka, et al.
Journal of Advanced Research (2021) Vol. 40, pp. 179-196
Open Access | Times Cited: 139
COVID‐19: immunopathology, pathophysiological mechanisms, and treatment options
Larissa E. van Eijk, Mathijs Binkhorst, Arno R. Bourgonje, et al.
The Journal of Pathology (2021) Vol. 254, Iss. 4, pp. 307-331
Open Access | Times Cited: 122
Acute and Post-Acute Neurological Complications of COVID-19
Ali Al-Ramadan, Omar Rabab’h, Jawad Shah, et al.
Neurology International (2021) Vol. 13, Iss. 1, pp. 102-119
Open Access | Times Cited: 92
Rogue antibodies could be driving severe COVID-19
Roxanne Khamsi
Nature (2021) Vol. 590, Iss. 7844, pp. 29-31
Closed Access | Times Cited: 91
Preparing for the long-haul: Autonomic complications of COVID-19
Nicholas Larsen, Lauren E. Stiles, Mitchell G. Miglis
Autonomic Neuroscience (2021) Vol. 235, pp. 102841-102841
Open Access | Times Cited: 84
Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection
Alex Richter, Adrian M. Shields, Abid Karim, et al.
Clinical & Experimental Immunology (2021) Vol. 205, Iss. 2, pp. 99-105
Open Access | Times Cited: 71
Latent rheumatic, thyroid and phospholipid autoimmunity in hospitalized patients with COVID-19
Juan‐Manuel Anaya, Diana M. Monsalve, Manuel Rojas, et al.
Journal of Translational Autoimmunity (2021) Vol. 4, pp. 100091-100091
Open Access | Times Cited: 62
Multiple-Organ Complement Deposition on Vascular Endothelium in COVID-19 Patients
Paolo Macor, Paolo Durigutto, Alessandro Mangogna, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 1003-1003
Open Access | Times Cited: 62
Autoantibodies Neutralizing Type I Interferons in 20% of COVID-19 Deaths in a French Hospital
Angélique Chauvineau‐Grenier, Paul Bastard, Antoine Servajean, et al.
Journal of Clinical Immunology (2022) Vol. 42, Iss. 3, pp. 459-470
Open Access | Times Cited: 62
Neuroimmune disorders in COVID-19
Helena Ariño, Rosie Heartshorne, Benedict Michael, et al.
Journal of Neurology (2022) Vol. 269, Iss. 6, pp. 2827-2839
Open Access | Times Cited: 49
Inactive disease in patients with lupus is linked to autoantibodies to type I interferons that normalize blood IFNα and B cell subsets
Hannah F. Bradford, Liis Haljasmägi, Madhvi Menon, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 1, pp. 100894-100894
Open Access | Times Cited: 27
Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know
Wioleta M. Zelek, R. A. Harrison
Immunobiology (2023) Vol. 228, Iss. 3, pp. 152393-152393
Open Access | Times Cited: 27
Pro Inflammatory Cytokines Profiles of Patients With Long COVID Differ Between Variant Epochs
Ravindra Ganesh, Siddhant Yadav, Ryan T. Hurt, et al.
Journal of Primary Care & Community Health (2024) Vol. 15
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top